Cargando…

Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments

In this paper, we review the management of neonatal opioid withdrawal syndrome (NOWS) and clinical pharmacology of primary treatment agents in NOWS, including morphine, methadone, buprenorphine, clonidine, and phenobarbital. Pharmacologic treatment strategies in NOWS have been mostly empirical, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Fei, Ng, Chee M., Bada, Henrietta S., Leggas, Markos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301571/ https://www.ncbi.nlm.nih.gov/pubmed/33650314 http://dx.doi.org/10.1111/cts.12994

Ejemplares similares

Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
por: Eudy‐Byrne, Rena, et al.
Publicado: (2021)

Corrigendum to: Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Publicado: (2022)

Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model
por: Sithisarn, Thitinart, et al.
Publicado: (2022)

Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice
por: Dunn, Amelia D., et al.
Publicado: (2023)

Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model
por: Safa, Alireza, et al.
Publicado: (2021)

Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS)
por: Czynski, Adam, et al.
Publicado: (2023)

Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS)
por: Stevens, Sarah, et al.
Publicado: (2021)

Addressing drivers of healthcare utilization for neonatal opioid withdrawal syndrome
por: Glait, Megan, et al.
Publicado: (2022)

Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns
por: Esposito, Daina B., et al.
Publicado: (2022)

Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome
por: Baldo, Brian A.
Publicado: (2022)

Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017
por: Eaves, Emery R., et al.
Publicado: (2021)

481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
por: Tobacyk, Julia, et al.
Publicado: (2023)

Economic Evaluation of Interventions for Treatment of Neonatal Opioid Withdrawal Syndrome: A Review
por: Lee, Evelyn, et al.
Publicado: (2021)

Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome
por: MacMillan, Kathryn Dee L., et al.
Publicado: (2022)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

A Comparison of Morphine Delivery in Neonatal Opioid Withdrawal
por: Chisamore, Brian, et al.
Publicado: (2016)

A Novel Strategy for Attenuating Opioid Withdrawal in Neonates
por: Santoro, Giovanni C, et al.
Publicado: (2016)

Fentanyl withdrawal: Iatrogenic opioid withdrawal syndrome: case report
Publicado: (2022)

Procedural pain assessment in neonates at risk of neonatal opioid withdrawal syndrome: a scoping review protocol
por: Lavergne, Julianna, et al.
Publicado: (2023)

Prenatal Exposures Are Associated With Worse Neurodevelopmental Outcomes in Infants With Neonatal Opioid Withdrawal Syndrome
por: Benninger, Kristen L., et al.
Publicado: (2020)

Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop
por: Simon, Alan E., et al.
Publicado: (2021)

Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning
por: Manigault, Andrew W., et al.
Publicado: (2022)

EEG Findings in Infants With Neonatal Abstinence Syndrome Presenting With Clinical Seizures
por: Palla, Murali Reddy, et al.
Publicado: (2019)

Association of a Simplified Finnegan Neonatal Abstinence Scoring Tool With the Need for Pharmacologic Treatment for Neonatal Abstinence Syndrome
por: Devlin, Lori A., et al.
Publicado: (2020)

Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol
por: Mills-Huffnagle, Sara, et al.
Publicado: (2023)

Systemic opioid regimens for postoperative pain in neonates
por: Kinoshita, Mari, et al.
Publicado: (2023)

Systemic opioid regimens for postoperative pain in neonates
por: Kinoshita, Mari, et al.
Publicado: (2023)

Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome
por: Jenkins, Dorothea D., et al.
Publicado: (2021)

Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study
por: Sutter, Mary Beth, et al.
Publicado: (2022)

Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome
por: Mahnke, Amanda H., et al.
Publicado: (2022)

Single high-dose buprenorphine for opioid craving during withdrawal
por: Ahmadi, Jamshid, et al.
Publicado: (2018)

Is this ‘complicated’ opioid withdrawal?
por: Parkar, S.R., et al.
Publicado: (2006)

Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study
por: Wachman, Elisha M., et al.
Publicado: (2020)

Fentanyl: Fetal bladder atony following in-utero exposure; neonatal opioid withdrawal syndrome: case report
Publicado: (2021)

Opioid dose regimen shapes mesolimbic adaptations
por: Cahill, Catherine M.
Publicado: (2020)

Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants
por: Devlin, Lori A., et al.
Publicado: (2021)

Elucidating the context for implementing nonpharmacologic care for neonatal opioid withdrawal syndrome: a qualitative study of perinatal nurses
por: Shuman, Clayton J., et al.
Publicado: (2021)

Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome
por: Radhakrishna, Uppala, et al.
Publicado: (2023)

Lofexidine for Treating Opioid Withdrawal Syndrome in Palliative Care Patients
por: Nair, Abhijit S
Publicado: (2018)

Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine
por: Go, Se-Il, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88ajdmfdnqu03l4jj8ffsd4t69